The agreement extended Mr. Rittenmeyer’s role as executive chair for one year. He was originally slated to serve as executive chair through 2022.
Mr. Rittenmeyer, who served as CEO and executive chair of Dallas-based Tenet for nearly four years before leaving the CEO role in 2021, will be an executive adviser to Tenet’s CEO and the company’s board from Jan. 1, 2024, through the end of 2025, according to the amended employment agreement.
Under the agreement, Tenet will pay Mr. Rittenmeyer an annual salary of $750,000, and he’ll be eligible to receive annual bonuses.
Tenet, a 60-hospital system, reported a net income of $1.5 billion on revenue of $19.5 billion in 2021. A year earlier, the for-profit company reported a net income of $768 million on revenue of $17.6 billion.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
